Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11926616 Aminopyrazine diol compounds as PI3K-γ inhibitors

Patent 11926616 was granted and assigned to Incyte on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Incyte

Current Assignee

Incyte

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119266160

Patent Inventor Names

Nikoo Falahatpisheh0

Lixin Shao0

Andrew P. Combs0

Stacey Shepard0

Date of Patent

March 12, 2024

Patent Application Number

175408600

Date Filed

December 2, 2021

Patent Citations

‌

US Patent 8841308 Pyrazin-2-amines useful as inhibitors of ATR kinase

‌

US Patent 8841337 Compounds useful as inhibitors of ATR kinase

‌

US Patent 8841450 Compounds useful as inhibitors of ATR kinase

‌

US Patent 8846917 Compounds useful as inhibitors of ATR kinase

‌

US Patent 8846918 Compounds useful as inhibitors of ATR kinase

‌

US Patent 8962623 Aminopyrazine compounds

‌

US Patent 8969356 Compounds useful as inhibitors of ATR kinase

‌

US Patent 9035053 Processes for making compounds useful as inhibitors of ATR kinase

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11926616 Aminopyrazine diol compounds as PI3K-γ inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API